Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29,037 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Classification Tree-Based Machine Learning to Visualize and Validate a Decision Tool for Identifying Malnutrition in Cancer Patients.
Yin L, Lin X, Liu J, Li N, He X, Zhang M, Guo J, Yang J, Deng L, Wang Y, Liang T, Wang C, Jiang H, Fu Z, Li S, Wang K, Guo Z, Ba Y, Li W, Song C, Cui J, Shi H, Xu H; Investigation on Nutrition Status and Clinical Outcome of Common Cancers (INSCOC) Group. Yin L, et al. Among authors: he x. JPEN J Parenter Enteral Nutr. 2021 Nov;45(8):1736-1748. doi: 10.1002/jpen.2070. Epub 2021 Mar 15. JPEN J Parenter Enteral Nutr. 2021. PMID: 33415743
Evaluation of the Global Leadership Initiative on Malnutrition Criteria Using Different Muscle Mass Indices for Diagnosing Malnutrition and Predicting Survival in Lung Cancer Patients.
Yin L, Lin X, Li N, Zhang M, He X, Liu J, Kang J, Chen X, Wang C, Wang X, Liang T, Liu X, Deng L, Li W, Song C, Cui J, Shi H, Xu H. Yin L, et al. Among authors: he x. JPEN J Parenter Enteral Nutr. 2021 Mar;45(3):607-617. doi: 10.1002/jpen.1873. Epub 2020 Jun 1. JPEN J Parenter Enteral Nutr. 2021. PMID: 32386328
Is hand grip strength a necessary supportive index in the phenotypic criteria of the GLIM-based diagnosis of malnutrition in patients with cancer?
Yin L, Lin X, Zhao Z, Li N, He X, Zhang M, Yang J, Guo Z, Li Z, Wang K, Weng M, Cong M, Li S, Li T, Ma H, Ba Y, Li W, Cui J, Liu J, Song C, Shi H, Xu H. Yin L, et al. Among authors: he x. Support Care Cancer. 2021 Jul;29(7):4001-4013. doi: 10.1007/s00520-020-05975-z. Epub 2021 Jan 4. Support Care Cancer. 2021. PMID: 33398429
Fat mass assessment using the triceps skinfold thickness enhances the prognostic value of the Global Leadership Initiative on Malnutrition criteria in patients with lung cancer.
Yin L, Fan Y, Lin X, Zhang L, Li N, Liu J, Guo J, Zhang M, He X, Liu L, Zhang H, Shi M, Chong F, Chen X, Wang C, Wang X, Liang T, Liu X, Deng L, Li W, Song C, Cui J, Shi H, Xu H; Investigation on Nutrition Status and Clinical Outcome of Common Cancers (INSCOC) Group. Yin L, et al. Among authors: he x. Br J Nutr. 2022 May 28;127(10):1506-1516. doi: 10.1017/S0007114521002531. Epub 2021 Jul 5. Br J Nutr. 2022. PMID: 34218831
Comparison of the performance of the GLIM criteria, PG-SGA and mPG-SGA in diagnosing malnutrition and predicting survival among lung cancer patients: A multicenter study.
Huo Z, Chong F, Yin L, Li N, Liu J, Zhang M, Guo J, Fan Y, Zhang L, Lin X, Zhang H, Shi M, He X, Lu Z, Fu Z, Guo Z, Li Z, Zhou F, Chen Z, Ma H, Zhou C, Chen J, Wu X, Li T, Zhao Q, Weng M, Yao Q, Liu M, Yu H, Zheng J, Cui J, Li W, Song C, Shi H, Xu H; Investigation on Nutrition Status and Clinical Outcome of Common Cancers (INSCOC) Group. Huo Z, et al. Among authors: he x. Clin Nutr. 2023 Jun;42(6):1048-1058. doi: 10.1016/j.clnu.2023.04.021. Epub 2023 Apr 27. Clin Nutr. 2023. PMID: 37178592
Grip-Strength-Lean-Mass Index (GSLMI) as a valuable tool for sarcopenia diagnosis and survival prognosis in cancer patients: a nationwide multicenter cohort study.
Huo Z, Chong F, Luo S, Li N, Tong N, Lu Z, Guo J, Zhang L, Lin X, Zhang M, Zhang H, Shi M, He X, Liu J, Song C, Shi H, Xu H. Huo Z, et al. Among authors: he x. J Nutr Health Aging. 2024 Nov 11;29(1):100409. doi: 10.1016/j.jnha.2024.100409. Online ahead of print. J Nutr Health Aging. 2024. PMID: 39532047 Free article.
Immunogenicity and safety of SARS-CoV-2 recombinant protein vaccine (CHO cell) LYB001 as a heterologous booster following two- or three-dose inactivated COVID-19 vaccine in adults aged ≥18 years: interim results of a randomized, active-controlled, double-blinded, phase 3 trial.
Yang BF, Jin J, He XR, Yang ZH, Qian X, Tong YQ, Ke CX, Li ZH, Li ZX, Zhong LF, Gan ZH, Zhang XF, Zeng Y. Yang BF, et al. Among authors: he xr. Expert Rev Vaccines. 2024 Dec 25. doi: 10.1080/14760584.2024.2446288. Online ahead of print. Expert Rev Vaccines. 2024. PMID: 39720838
29,037 results
You have reached the last available page of results. Please see the User Guide for more information.